[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE464616B - Foerfarande foer framstaellning av ett immunosuppressivt medel innefattande ett konjugat av d-glutaminsyra-d-lysinsampolymer och ett antingen - Google Patents

Foerfarande foer framstaellning av ett immunosuppressivt medel innefattande ett konjugat av d-glutaminsyra-d-lysinsampolymer och ett antingen

Info

Publication number
SE464616B
SE464616B SE7801268A SE7801268A SE464616B SE 464616 B SE464616 B SE 464616B SE 7801268 A SE7801268 A SE 7801268A SE 7801268 A SE7801268 A SE 7801268A SE 464616 B SE464616 B SE 464616B
Authority
SE
Sweden
Prior art keywords
copolymes
lysin
conjugated
procedure
cell
Prior art date
Application number
SE7801268A
Other languages
English (en)
Other versions
SE7801268L (sv
Inventor
D H Katz
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of SE7801268L publication Critical patent/SE7801268L/sv
Publication of SE464616B publication Critical patent/SE464616B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S524/00—Synthetic resins or natural rubbers -- part of the class 520 series
    • Y10S524/90—Antigen-antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7801268A 1977-02-03 1978-02-02 Foerfarande foer framstaellning av ett immunosuppressivt medel innefattande ett konjugat av d-glutaminsyra-d-lysinsampolymer och ett antingen SE464616B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/764,586 US4191668A (en) 1977-02-03 1977-02-03 Induction of immunological tolerance

Publications (2)

Publication Number Publication Date
SE7801268L SE7801268L (sv) 1978-08-04
SE464616B true SE464616B (sv) 1991-05-27

Family

ID=25071153

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7801268A SE464616B (sv) 1977-02-03 1978-02-02 Foerfarande foer framstaellning av ett immunosuppressivt medel innefattande ett konjugat av d-glutaminsyra-d-lysinsampolymer och ett antingen

Country Status (17)

Country Link
US (1) US4191668A (sv)
JP (1) JPS53121943A (sv)
AU (1) AU515181B2 (sv)
BE (1) BE863656A (sv)
CA (1) CA1118347A (sv)
CH (1) CH644521A5 (sv)
DE (1) DE2804457C2 (sv)
DK (1) DK155174C (sv)
FI (1) FI780312A (sv)
FR (1) FR2379287A1 (sv)
GB (1) GB1599454A (sv)
LU (1) LU78997A1 (sv)
MX (1) MX6266E (sv)
NL (1) NL7801220A (sv)
NO (1) NO153419C (sv)
SE (1) SE464616B (sv)
ZA (1) ZA78613B (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276206A (en) * 1979-01-18 1981-06-30 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4220565A (en) * 1979-01-18 1980-09-02 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4253995A (en) * 1980-02-11 1981-03-03 Scripps Clinic And Research Foundation Immunochemical conjugates: method and composition
US4253996A (en) * 1980-02-13 1981-03-03 Scripps Clinic And Research Foundation Immunochemical conjugates: method and composition
DE3114362C2 (de) * 1980-04-11 1983-08-18 Toshiyuki Prof. Nara Hamaoka Verfahren zur Herstellung eines Antikörpers bzw. Antiserums, Verwendung dieses Verfahrens zur Gewinnung von Säugetierzellen, welche fähig sind, einen solchen Antikörper zu erzeugen und Verwendung des so hergestellten Antikörpers bzw. Antiserums zur Immunoprüfung
EP0077158A1 (en) * 1981-10-09 1983-04-20 Beecham Group Plc Modified allergens
US6022544A (en) 1983-01-24 2000-02-08 The John Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US5126131A (en) * 1983-01-24 1992-06-30 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of antigen-competitive conjugates.
US5370871A (en) * 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US5017648A (en) * 1986-05-30 1991-05-21 La Jolla Pharmaceutical Company D-GL conjugate therapy
US4950469A (en) * 1986-05-30 1990-08-21 La Jolla Pharmaceutical Company D-GL conjugate therapy
US4950713A (en) * 1986-05-30 1990-08-21 La Jolla Pharmaceutical Company Conjugates of D-glutamic acid: D-lysine copolymer and certain biochemicals
CA1309558C (en) * 1986-05-30 1992-10-27 Quidel D-gl conjugate therapy
US5162515A (en) * 1990-01-16 1992-11-10 La Jolla Pharmaceutical Company Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus
US5552391A (en) * 1990-01-16 1996-09-03 La Jolla Pharmaceutical Company Chemically-defined non-polymeric valency platform molecules and conjugates thereof
US5268454A (en) 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
US5391785A (en) * 1990-01-16 1995-02-21 La Jolla Pharmaceutial Company Intermediates for providing functional groups on the 5' end of oligonucleotides
IE922292A1 (en) * 1991-07-15 1993-01-27 Jolla Pharma Modified phosphorous intermediates for providing functional¹groups on the 5' end of oligonucleotides
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US8071737B2 (en) 1995-05-04 2011-12-06 Glead Sciences, Inc. Nucleic acid ligand complexes
US5874409A (en) 1995-06-07 1999-02-23 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US6410775B1 (en) * 1995-06-07 2002-06-25 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
US6458953B1 (en) 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
US6399578B1 (en) 1998-12-09 2002-06-04 La Jolla Pharmaceutical Company Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same
US7084256B2 (en) * 1999-09-24 2006-08-01 Large Scale Biology Corporation Self antigen vaccines for treating B cell lymphomas and other cancers
US20030044420A1 (en) * 1999-09-24 2003-03-06 Mccormick Alison A. Self antigen vaccines for treating B cell lymphomas and other cancers
JP2003535208A (ja) 2000-06-08 2003-11-25 ラ ホヤ ファーマシューティカル カンパニー 高分子量ポリエチレン・オキシドを含む多価プラットホーム分子

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3825525A (en) * 1969-08-06 1974-07-23 Beecham Group Ltd Allergens reacted with carbodiimides
GB1282163A (en) * 1969-08-06 1972-07-19 Beecham Group Ltd Modified allergens and a process for their preparation

Also Published As

Publication number Publication date
ZA78613B (en) 1978-12-27
US4191668A (en) 1980-03-04
BE863656A (fr) 1978-05-29
DE2804457C2 (de) 1984-04-12
DK155174C (da) 1989-07-10
DK49178A (da) 1978-08-04
CA1118347A (en) 1982-02-16
MX6266E (es) 1985-02-27
NO153419C (no) 1986-03-19
CH644521A5 (de) 1984-08-15
NL7801220A (nl) 1978-08-07
SE7801268L (sv) 1978-08-04
FI780312A (fi) 1978-08-04
DE2804457A1 (de) 1978-08-10
AU3293378A (en) 1979-08-09
FR2379287B1 (sv) 1980-08-29
FR2379287A1 (fr) 1978-09-01
NO153419B (no) 1985-12-09
GB1599454A (en) 1981-10-07
JPS53121943A (en) 1978-10-24
LU78997A1 (fr) 1978-06-21
JPH0428689B2 (sv) 1992-05-15
AU515181B2 (en) 1981-03-19
DK155174B (da) 1989-02-27
NO780366L (no) 1978-08-04

Similar Documents

Publication Publication Date Title
SE464616B (sv) Foerfarande foer framstaellning av ett immunosuppressivt medel innefattande ett konjugat av d-glutaminsyra-d-lysinsampolymer och ett antingen
SE432432B (sv) Forfarande och medel for fornetning av halogenhaltiga polymerer
SE7804376L (sv) Forfarande och medel for tryckning
SE7802250L (sv) Tillvextbefremjande medel
FI802190A (fi) Vinylpolymer med acetylacetoxigrupper foerfarande foer dess framstaellning och medel innehaollande det
FI773880A (fi) Foerfarande foer framstaellning av en raefflad vals och motsvarande vals
SE7713322L (sv) Insekticidala och akaricidala medel
FI801111A (fi) Foerfarande och medel foer att avlaegsna askorbinsyra ur vattenloesningar
SE7810393L (sv) Insekticida och akaricida medel
FI781004A (fi) Foerfarande och anordning foer gjutning av staolstaong
DK144657C (da) Fremgangsmaade til fremstilling af antibiotikum c-15003 p-3
SE7810587L (sv) Hopfestningsorgan och forfarande for framstellning av detta
BE864584A (fr) Composes azoiques et leur preparation
FI773505A (fi) Foerfaringssaett och medel foer framstaellning av ett vattenavvisande byggnadsmaterial
FI783406A (fi) Anordning och foerfarande foer utbredning av traodar
SE431292B (sv) Forfarande och anordning for sprayning
SE7906484L (sv) Langstreckt, komprimerat foremal och forfarande for tillverkning av ett sadant
SE7802024L (sv) Forfarande for framstellning av pyrrolokinoxalinoner och pyrrolobensodiazepinoner
FI773574A (fi) Foerfarande och anordning foer framstaellning av ett isolerande hoelje av bryggbildande isolermaterial
FI801988A (fi) Farmaceutiskt preparat och foerfarande foer dess framstaellning
SE424334B (sv) Fast formkompositon innefattande ett novolockharts av fenol-formaldehyd, en sterkelse och ett aminderivat
FI783350A (fi) Foerfarande och anordning foer soempressning av roerformiga klaeddelar
SE7812832L (sv) 2'-n-acyl och alkyl-6'-n-alkyl- och 6',6'-di-n-alkyl-derivat av fortimiciner a och b
SE415740B (sv) Apparat for tverkapning av ett extruderat emne till forutbestemda lengder och hopsmeltning av endarna pa dessa kapade lengder
BE870887A (fr) Composes indoliques nouveaux